The utility of changes in serum levels of C-terminal telopeptide of type I collagen in predicting patient response to oral monthly ibandronate therapy.
Hochberg
Marc C
MC
Division of Rheumatology & Clinical Immunology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA. mhochber@medicine.umaryland.edu
Silverman
Stuart L
SL
Barr
Charles E
CE
Miller
Paul D
PD